Several AIDS cohort studies observe that the incubation period between HIV infection and AIDS onset can be shorter than 3 years in about 10% seropositive individuals, or longer than 10 years in about 10-15% individuals. On the other hand, many individuals remain seronegative even after multiple exposures to HIV. These distinct outcomes have recently been correlated with some mutant genes in HIV co-receptors (e.g., CCR5,CCR2 and CXCR4). For instance, the mutant alleles A32 and m303 of CCRS may provide full protection against HIV infection in homozygotes and partial protection in heterozygotes; moreover, infected heterozygotes may progress more slowly than individuals who have no mutant alleles. Frequencies of these mutant alleles are not very low in Caucasian populations, therefore, their effects may not be insignificant. Based on available data, we propose a onesex model with susceptibles classified as having no, partial or full natural resistance to HIV infection, and infecteds classified as rapid, normal or slow progressors. Our goals are to investigate the impact of such heterogeneity on the spread of HIV and to identify key parameters. The basic reproductive number Ro is derived from a simplified model. The relative contributions to Ro from the three groups of infecteds are investigated. We present a rough estimating procedure making use of limited data to estimate some new parameters specific to our model. Finally the rough estimating procedure is applied to an example focusing on CCR5-A32 in San Francisco gay men. The relative contributions to Ro among the three infected groups are compared using two different classifying criteria for infecteds. Under given assumptions, we conclude that, without any intervention, HIV infection will continue to spread in this population and the epidemic is mainly driven by the normal progressors. The transmission rates from infecteds are identified as key parameters.
INTRODUCTION
within the first 2-3 years (rapid progressors). On the other hand, many individuals remain seronegative The studies of Sheppard, Lang and Ascher (1993) even after multiple exposures to HIV from infected and Phair (1994) find that about 10-15% of HIV partners (Detels et nl. 1994, Paxton et al. 1996 , infected individuals remain AIDS free for 10 years or Fowke et al. 1996) . These distinct outcomes pose an longer (non-progressors), while another 10% progress interesting question to HIVIAIDS researchers: What *Corresponding Author: Fax: +41-31-631 38 70; E-mail: sfshsu@math-stat.unibe.ch makes the difference? Genetic heterogeneity among individuals may contribute significantly. Several recent studies have demonstrated the protective effects of certain mutant genes on HIV infection orland AIDS pathogenesis. For instance, Samson et nl. (1996) show that a mutant allele, A32, of CCRS chemokine receptor gene is present at a high frequency of 0.092 in Caucasian populations. The frequencies of homozygotes and heterozygotes for the mutation are about 1% and 16%, respectively. However, in a cohort of HIV-1 infected Caucasian patients, the heterozygote frequency is 35% lower than in the general population and no homozygotes with two A32 alleles are found. These observations suggest A32 may provide, at least partial, resistance to HIV-1 infection. Dean et al. (1996) report the same mutant allele with a similar frequency (-10%) in the Caucasian population of the United States. Their results indicate that the homozygotes with two A32 alleles may escape from HIV-1 infection and heterozygous infecteds may have a slower progression than other infecteds. Recently Quillent et al. (1998) characterize another CCRS gene mutation, m303, which is present among Europeans at an allele frequency of under 1%. Individuals with genotype m303lm303 or A32/m303 acquire resistance to HIV-I infection. Similarly, the m303 heterozygosity may give partial protection against infection and slow down the progression once infected.
In another chemokine, CCR2, Smith et a[. (1997) describe a mutation, 641, which occurs at an allele frequency of 10-15% among Caucasians and African Americans. Although this mutant gene dose not seem to provide protection against HIV-1 infection, it does indicate a 2-4 years delay of progression among infecteds. Moreover, the effects of CCR5-A32 and CCR2-641 on AIDS progression are determined as genetically independent. Among rapid progressors (AIDS onset less than 3 years since infection), about 38-45% do not have either of the two mutant alleles, A32 and 641; while among nonprogressors (avoid AIDS for 16 years or more), about 28-29% can be explained by a mutant allele in either gene. genotype have a significantly lower relative hazard to AIDS onset and the protection is approximately twice that seen with CCR2 or CCRS protection. Moreover, CCR and SDFl protection seem to be additive. All the information above clearly indicates the existence of genetic heterogeneity with respect to susceptibility to HIV infection and to rate of AIDS progression in general populations. Such kind of heterogeneity has not been studied in the modeling literature. Our special interest in this paper is to investigate, using mathematical models. the impact of such heterogeneity on the spread of HIV and to identify key parameters. To accommodate the genetic heterogeneity on one side and being limited by data availability on the other side, we propose a deterministic one-sex model with susceptibles classified as having no, partial or complete resistance to HIV infection and infecteds as rapid, normal or slow progressors. The details of the general model are presented in Section 2. Under some simplifying assumptions, the basic reproductive number, Ro (Diekmann et al. 1990) , is obtained in terms of model parameters in Section 3. Based on the limited available information and scarce data, a rough estimation of some parameters is carried out in Section 4. In Section 5 the rough estimating procedure is applied to an example focusing on CCRS-A32 among gay men in San Francisco. The relative contributions to Ro among the three infected groups are compared under two different classifying criteria for infecteds. Finally some concluding remarks are provided in Section 6.
MODEL DESCRIPTION
As the first step in our efforts to incorporate genetic heterogeneity in epidemiological models, we focus on the simplest possible scenario, i.e., a homosexually-active homogeneously-mixing population, to investigate the role of differential susceptibility and pathogenesis in HIV infected populations.
Based on the level of natural resistance to HIV, susceptibles are classified into three groups: no resistance (SI), partial resistance (S2) and complete resistance (5'3). We assume that &-individuals never become infected. Similarly, based on AIDS pathogenesis, infecteds are classified into three groups: rapid progressor (II), normal progressor (12) and slow progressor (13) . AIDS patients are assumed sexually inactive, thus they do not play a role in HIV transmission and are not included in our model. Throughout this paper, the index i refers to group of susceptibles and the index j to group of infecteds.
We (1) that is, a large fraction of individuals has no resistance, a small fraction has partial resistance, and an even smaller fraction has complete resistance. All individuals are subject to the common percapita natural removal rate, y . The average number of partners per unit time is denoted by ci (i (2)
The infectiousness of Ij individuals is reflected by the per-partnership transmission rate, 4 = 1,2,3).
We assume that rapid progressors (1,) have the highest viral load, thus are most infectious; and that slow progressors (I3) have the lowest viral load, thus are least infectious. More specifically, we hypothesize the following relation:
It has been shown that the viral load and the infectiousness may change dramatically during the incubation period. However, to incorporate this fact we would need to keep track of the "age" of infection for each individual and end up with a complicated model. For the sake of simplicity, here we assume gj are constant as in Anderson, Gupta and May (1991) and in McLean and Blower (1993) .
During the partnership between an S2-individual and an I,-individual, the transmission rate Jj of the infected partner is reduced to .xj (3j, with 0 < x, u, 1 to account for partial resistance to HIV in Sh-individuals. Newly infected Si-individuals ( i = 1.2) join the three infected groups with respective proportions Ai, which satisfy We expect the new infecteds who come from S1 to generate a larger fraction of rapid progressors (II) and a smaller fraction of slow progressors (I3) than those coming from S2, that is, Because we are looking at a homosexually active population, processes of pair formation and dissolution are not followed explicitly, instead, a proportional mixing pattern is assumed. The total number of sexual partnerships is defined as 
Si : = ci S; oi .
(9) Relation (3) implies that the multipliers These newly infected individuals enter the class I; 0' = 1,2,3) at the rate bl >_ 1 and b3 < 1.
2
Currently there are no data that throw some light on pj:= Cjj6,.
(10) whether or not the reduction factors xj for Pj depend i=l on j . To continue our goal of analyzing the simplest called "birth rate or the incidence of I,. We denote possible genetic-epidemiological model, we assume the overall incidence by S1 as that .xi = x for all j. Relevant variables can now be 2 3 simplified as follows: R : =~s .
=CW, (11)
where equality holds because of condition (4). We are now ready to present our mathematical model: + ---
~+ T I P+Y2 p+73
with Because all elements on the right hand side of (24) are positive, it is clear X > 0. Therefore, X is the dominant eigenvalue of M D ' , which is also referred to the basic reproductive number, Ro (Diekmann et al. 1990 
ESTIMATION OF NEW PARAMETERS
Estimates of most social-demographic and biomedical parameters (e.g., per-capita natural removal rate. p; recruitment rate, T ; average number of partners per unit time, c; overall per-partnership transmission rate.
P; and overall per-capita rate of progression, y) ally estimated based on data cumulatively collected over long periods of time in cohort studies. They do not refer to prevalence nor to incidence, but may be viewed as "average" fractions for the given period of time. Using our simplified model together with some additional assumptions, we now show how the "retrospective" h;; can be used to give an estimate of its "prospective" counterpart, Aj.
First we let Q:= S2/S1. Since the majority of susceptibles are in S1, it is expected that 0 < 0 < 1.
From expressions (1 l), (1 8) and (19), we obtain the following:
The available hd and qj are obtained from cohort studies where individuals did not become seropositive all at the same time. Moreover, the longitudinal patterns of hji and qj are not known. To make rough use of these fractions, we assume that they are constant over time. This assumption helps relate them with the incidence associated with individuals who seroconverted at about the same time.
With the given qj, the incidence of Ij can be expressed as
In our notation and under the above-mentioned assumption, the "retrospective" information about the incidence is described by for j = 1,2,3. Rearranging the above equations, the Ai can then be expressed as Summing the above two equations over j and making use of condition (4), one obtains where are known quantities. Here the unknown quantity involving x Q can be evaluated by either Plugging the results of expressions (37) and (38) respectively into Equations (32) and (33) gives the required estimates for .f,.
We are aware of a potential problem with this rough estimatillg procedure. The quantities 771 and 712 come from q, and h,, which are assumed constant over time. This assumption may result in strange behaviors. For instance, from expression (37) one obtains 1 1 -71 ,*Q = --1 = -. 
With constant . w and 71, Equation (39) implies C) should be constant as well, which is not true in general, but is true when the population is at equilibrium. However, when the population is not at equilibrium, the estimates of fi, may still be reasonable if Q does not change much over time.
Although the above estimating procedure does not have a sound statistical base and depends on strong assumptions, it may provide sensible guesses, which may be useful especially under the current situation. Furthermore, it is important to note that, in some sense, this is the best that we can hope for given the fact that the available clinical data were not collected to address the questions raised by our model. Lack of data should not constrain the type of questions that may be raised. In fact, we hope that our model results may motivate the collection of the data required here. The application of this rough estimating procedure will be illustrated in the following example.
EXAMPLE
We choose the population of gay men in San Francisco as target with the focus on the mutation CCRS-A32 to illustrate the estimating procedure for Aj as well as to assess the relative contributions of the three infected groups to Ro. Whenever possible, we take parameter values specific for this population: otherwise we take values from other Caucasian AIDS cohorts.
As in McLean and Blower (19931, we use 1 /~ = 32 years, ri = 2000/year and l / a = 5/3 years. As for the value of PC, because normal progressors are the majority in the infected population, we assume P2c can be described by the parameter values estimated for the whole infected population, e.g., P2c = PC = 0.62lyear. No information about P1 and P3, or equivalently about bl and 63, is available, thus they are considered as free parameters. According to data on homosexually active men in the San Francisco City Clinic Cohort (SFCC) presented in Dean et al. (1996 , Table 11 ), the frequencies of the three genotypes are estimated as gl = 0.75, gz = 0.23 and g3 = 0.02. Based on pooled data of Caucasians in five AIDS cohorts (including SFCC) presented in Smith et al. (1997, Figure 3) , we define that rapid progressors have an incubation time of less than 3.5 years, slow progressors of more than 13 years, and normal progressors of in between 3.5 and 13 years; i.e., l / y l < 3.5 years, 3.5 years i 1/32 i 13 years and l/y3 > 13 years. Accordingly we choose yl = 1/2, 7 2 = 1/8 and y3 = 1/16 as an educated reasonable guess. When the AIDS criterion of 1993 is applied to these data (top panel in Figure 3 of Smith at al. 1997), the fractions of these three groups are approximated by ql = 0.115, qz = 0.645 and q 3 = 0.240, and the within group distributions are approximated by hll = 0.89, h12 = 0.1 1, hZl = 0.81, h22 = 0.19, h31 = 0.72 and h32 = 0.28. These values are only approximations due to three reasons: 1) they are estimated from a figure, not directly from counts; 2) this figure is constructed based on pooled data of five AIDS cohorts; and 3) in the figure CCR2-641 mutation is also considered in addition to CCR5-A32 mutation. However, these are the best approximations that we can get from published, aggregated data. We note that the frequency of heterozygotes in two European cohorts of seropositive Caucasians is 35% lower than in the general populations (Samson et al. 1996) .
Hence, we select the value of x = 1 -0.35 = 0.65.
With the above values of q, and h,, the q in (36) is calculated as 0.799, resulting in (I + xB) = 1.254. Using (32) and (33), we obtain f i l = 0.128, fi2 = 0.655, f13 = 0.217, f21 = 0.063, f22 = 0.605 and fi3 = 0.332. These fractions look reasonable and satisfy conditions (4) and (5) . Together with other parameters, the magnitude of Ro and relative contributions from the three infected groups can be assessed using (25). Because the value of x is suggested from geographically distinct populations, we decide to treat x first as a free parameter and then take the value of 0.65 for further investigation.
As shown in Figure 1 , the relative contribution of rapid progressors, Ql, is rather small, ranging between 0.05 and 0.23 with bl E [I, 41 and x E (0, I), and is more sensitive to bl than to x . The upper bound of bl is chosen for illustrative purpose. With bS t (0, I] and x E (0, I),the relative contribution of slow progressors, Q 3 , is mostly larger than Ql, but still less than unity with a range between 0 and 0.63. As can be seen from Figure 2 , the value of Q3 is also more sensitive to bl than to x . Because Q1 < 1 and Q3 < 1, the normal progressors contribute the most to Ro, with K evaluated by For 0 < x < 1, we obtain 1.95 < K < 2.50, which "guarantees" the disease will continue to spread in this population. When x is fixed at 0.65, the magnitude of Ro for different values of bl and b3 can be calculated using (25) as follows:
which is also plotted in Figure 3 . Because the coefficient of b3 is about 11.5 times of that of bl , Ro is much more sensitive to value of b3 than to bl. With bl E [1,4] and b3 E (0, 11, we obtain 0.053 5 Ql 5 0 . 2 1 2 and 0 < Q3 5 0.609, which are clearly less than unity. Hence, the normal progressors gives the major contribution to Ro with K = 2.308 > 1 (this fact is generally true for x E (0, 1) as presented in (40)).
The resulting range of Ro is between 2.43 and 4.20. When bl = 1 and b3 = 1, we obtain Ro = 3.84 with Ql = 0.053 < Q3 = 0.609; while when bl = 4 and Thus, depending on the values of bl and b3, the relative contribution of rapid progressors may be smaller or larger than that of slow progressors.
The way we classify rapid, normal and slow progressors based on incubation period in the above example is somehow arbitrary. However, there does not seem to be a standard classification presented in the literature. To investigate the effects of the classification, we now repeat the same evaluation with a different cut-off value, 216 years, for slow progressors. More specifically, we define rapid progressors as before, but slow progressors have an incubation period of at least 16 years, and thus normal progressors lie between 3. satisfy conditions (4) and (5) . When x is fixed at 0.65, the magnitude of RO for different values of bl and b3 can be calculated by the following formula:
which is also more sensitive to b3 than to b l ; however, the coefficient of 03 is only about 2 times of that of b l .
With hl E [ l , 41 and b3 E (0, I ] , we obtain 0.034 5 (21 < 0.136 and 0 < Q3 5 0.071, which are clearly less than unity. Moreover, Q l and Q3 here are smaller than the earlier evaluation due to larger fiz and f22 in r2 and a smaller 7% For Q3 the additional influence comes from much smaller fi:, and fi3 in 7 3 and a smaller 7 3 . The contribution to Ro from normal progressors is K = 3.583, which is larger than the K = 2.308 in the earlier evaluation also due to larger fiz and fz2 in ~2 and a smaller y2. The value of Ro ranges between 3.70 and 4.32, which is also larger than the earlier evaluation. When bl = 1 and 63 = 1, we obtain Ro = 3.96 with Ql = 0.034 < Q3 = 0.071; while when bl = 4 and b3 = 0.25, Ro = 4.14 with Q1 = 0.137 > Q3 = 0.018. As before, the relative magnitude between QI and Q3 depends on the values of bl and b3. 
CONCLUDING REMARKS
We have presented a novel model to incorporate genetic heterogeneity into HIV / AIDS epidemiology. The basic reproductive number for this model has been derived and the relative contributions from different infected groups have been discussed. Because published data are limited, values of some parameters are not available and have to be estimated in a rough way. Our rough estimating procedure for distributing fractions of infecteds, fi,., has provided reasonable estimates in the above example.
To improve the accuracy of this estimation, data collected in a prospective manner, e.g., keeping track of how many S, individuals become I, individuals, would be very helpful. However, it may take a long time and a lot of efforts to observe a sufficient number of new infection cases and follow them until AIDS onset. The alternative is to develop more sophisticated estimating procedures to make use of the retrospective data.
Among the three free parameters, i.e., x, bl and b3, the basic reproductive number Ro for the homosexual population in San Francisco seems to be more sensitive to factors of transmission rates, bl and b3, than to the reduction factor, x. Therefore, more efforts should be devoted to the estimation of 6,. or equivalently the transmission rates Bj. When x = 0.65, the value of Ro lies between 2.43 and 4.32. depending on classifying criterion for infecteds and values of b, and b3. Anyway, it clearly indicates that HIV infection will continue to spread in this population and the major contribution to Ro is from the normal progressors, who are the majority among infecteds. This implies HIV prevention and treatment interventions should certainly include this major group. Further investigation on effects of treatment and vaccination in this population will be published elsewhere (Hsu Schmitz 1999). The relative contribution from rapid progressors may be smaller or larger than that from slow progressors, again depending on classifying criterion for infecteds and values of bl and h3. A standard classifying criterion for infecteds will be welcomed and is awaited, so we will have less confusion when several studies are compared.
The estimation and evaluation applied to the example are mainly for illustrative purpose. The assumptions required by the model and the rough estimating procedure might not all be satisfied in the example population. For instance. the fractions qj and
hji might not be constant. Furthermore, treatment is commonly used in this population in recent years. Our model without considering treatment effects might not reflect the real epidemic. However, the main purposes of this exercise are: 1) to motivate clinical researchers to collect required data (e.g., -h, 4, x and j j ) and to standardize the classifying criterion for infecteds; and 2) to identify key parameters, e.g., 01 and b3.
In our model infecteds coming from S1 and those from S2 are pooled together. It would be more informative, and probably also more realistic, to have three infected groups specifically for S1 -individuals and another three infected groups for &-individuals. However, this will give three equations more in the model and make the analysis and interpretation Inore difficult. Moreover, this requires additional parameters to be estimated from more detailed data, which are not readily available.
As mentioned in the Introduction, there are several mutant alleles of different loci related to susceptibility to HIV odand rate of progression to AIDS. Thus, it may be more appropriate to consider a cornbined locus accommodating several relevant loci, instead of focusing on a single locus. For instance. Smith et al. (1997) combine the CCRS locus and the CCR2 locus into a compound locus. More data should also be collected to cover this aspect.
